PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ECL.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-88.15%
Negative gross profit growth while ECL.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-493.85%
Negative EBIT growth while ECL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-493.85%
Negative operating income growth while ECL.AX is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-100.00%
Negative net income growth while ECL.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.82%
Share change of 3.82% while ECL.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
8.50%
Diluted share change of 8.50% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
No Data
No Data available this quarter, please select a different quarter.
220.63%
5Y revenue/share CAGR 1.25-1.5x ECL.AX's 154.15%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
225.44%
3Y revenue/share CAGR above 1.5x ECL.AX's 79.01%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
407.05%
5Y OCF/share CAGR above 1.5x ECL.AX's 109.69%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
3727.79%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
-111.47%
Negative 5Y net income/share CAGR while ECL.AX is 327.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
41.62%
Below 50% of ECL.AX's 136.10%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
154.82%
5Y equity/share CAGR above 1.5x ECL.AX's 40.92%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
83.07%
3Y equity/share CAGR above 1.5x ECL.AX's 25.32%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
416.89%
AR growth of 416.89% while ECL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-0.00%
Inventory is declining while ECL.AX stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.00%
Asset growth of 0.00% while ECL.AX is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-3.67%
We have a declining book value while ECL.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
9.28%
Debt shrinking faster vs. ECL.AX's 85.13%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-48.46%
We cut SG&A while ECL.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.